TNXP Latest Headlines

Tonix Pharmaceuticals Q3 2026 Earnings Preview

at seekingalpha.com (Fri, 6-Nov 7:33 AM)

Tonix Sets Nov. 9 Call to Detail Q3 2026 Results and Operational Updates

Market Chameleon (Mon, 26-Oct 9:17 AM)

TNXP spotlights TNX-801 horsepox-based vaccine platform at World Vaccine Congress Europe, with Phase 1 timing tied to 2027 IND clearance

Market Chameleon (Thu, 15-Oct 9:46 AM)

Tonix (TNXP) adds ~21 million Medicare lives to TONMYA coverage, lifting Medicare access to 32 million

Market Chameleon (Tue, 22-Sep 7:51 AM)

Tonix’s TONMYA Net Sales Surge 197% and Coverage Expands—Pipeline Progress Marks Key Quarter for TNXP

Market Chameleon (Mon, 10-Aug 11:16 AM)

Tonix Pharmaceuticals Nearly Triples TONMYA Sales While Expanding Coverage to 136 Million Lives and Advancing R&D Pipeline

Market Chameleon (Mon, 10-Aug 7:30 AM)